Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Genome-wide association studies (GWASs) of medication use may contribute to understanding of disease etiology, could generate new leads relevant for drug discovery and can be used to quantify future risk of medication taking. Here, we conduct GWASs of self-reported medication use from 23 medication categories in approximately 320,000 individuals from the UK Biobank. A total of 505 independent genetic loci that meet stringent criteria (P 

Original publication




Journal article


Nat Commun

Publication Date





Aged, Biological Specimen Banks, Cardiovascular Diseases, Databases, Factual, Drug Utilization, Female, Gastrointestinal Diseases, Genetic Loci, Genome, Human, Genome-Wide Association Study, Humans, Male, Mental Disorders, Middle Aged, Musculoskeletal Diseases, Pharmacogenomic Testing, Prescription Drugs, Self Administration, Self Report, United Kingdom